Is $CLOV one of the most undervalued healthcare stocks?

**Clover Health (CLOV) is not one of the most undervalued healthcare stocks based on the screening criteria used in the query**. Here's the analysis:

1. **High P/E Ratio**: Clover Health has a P/E ratio of -4.69, which is considered high and suggests that the stock is overvalued relative to its earnings.
2. **Low P/B Ratio**: The Price-to-Book (P/B) ratio of 2.56 indicates that the stock is not significantly overvalued based on its book value.
3. **Low Price**: The closing price of $1.51 is lower than many other healthcare stocks, which could make it appear undervalued at first glance.

4. **Market Capitalization**: The market capitalization of Clover Health is not provided in the data, but it is likely to be small based on its low price and P/E ratio. Small-cap stocks can be more volatile and riskier than larger companies.

Based on these points, while Clover Health may seem undervalued due to its low price, the high P/E ratio suggests that it is actually overvalued relative to its earnings. The P/B ratio indicates that it is not overvalued based on its book value, but this alone does not make it one of the most undervalued stocks in the healthcare sector.